Author: Brittney Wheeler

Kory Lavine, MD, PhD, the Alan A. and Edith L. Wolff Professor of Cardiology at WashU Medicine, has received a $600,000 grant from the Additional Ventures Foundation — an organization that funds research into congenital heart disease — to study hypoplastic left heart syndrome.

Nusayba Bagegni, MD, an associate professor at WashU Medicine, has been awarded a 2024 Early Career Cancer Clinical Investigator Award from the National Cancer Institute (NCI), part of the National Institutes of Health (NIH).

People with severe, treatment-resistant depression who received vagus nerve stimulation therapy showed improvement in depressive symptoms, quality of life and ability to complete everyday tasks, according to a national clinical trial led by researchers at WashU Medicine.

Burel R. Goodin, a professor of anesthesiology at WashU Medicine, has received more than $3 million from the National Institutes of Health (NIH) to support postdoctoral training.

A new, artificial intelligence-based method of analyzing mammograms, developed by researchers at WashU Medicine, identified individuals at high risk of developing breast cancer more accurately than the standard, questionnaire-based method did.

Results from a clinical trial conducted at WashU Medicine showed adding the investigational drug itacitinib to standard care for “half-matched” stem cell transplantation may reduce rates of graft-versus-host disease.

The Foundation for Anesthesia Education and Research has announced that Alex Evers, MD, the Henry E. Mallinckrodt Professor of Anesthesiology at Washington University School of Medicine in St. Louis, will receive the foundation’s 2024 Mentoring Excellence in Research Award. 

Siteman Cancer Center’s new building for outpatient care will be named the Gary C. Werths Building. A transformative commitment by the late Werths and his husband, Richard Frimel, will support cancer research and medical student scholarships.

Adam Eggebrecht, an associate professor of radiology at WashU Medicine, received $4 million from the National Institutes of Health (NIH) to disseminate powerful cloud-based resources to the brain mapping community. 

Researchers at WashU Medicine engineered a yeast probiotic to deliver immunotherapy to the gut where it reduced gastrointestinal tumors in mice, offering a potentially novel strategy to target hard-to-reach gut cancers.